Adicon Holdings (HKSE:09860) Accounts Receivable : HK$1,916 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Adicon Holdings Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Adicon Holdings's accounts receivables for the quarter that ended in Dec. 2023 was HK$1,916 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Adicon Holdings's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was HK$-0.65.

Adicon Holdings Accounts Receivable Historical Data

The historical data trend for Adicon Holdings's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adicon Holdings Accounts Receivable Chart

Adicon Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Accounts Receivable

1,171.26

1,573.99

2,282.45

1,915.90

Adicon Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Receivable	Get a 7-Day Free Trial			1,573.99	-	2,282.45	2,201.92	1,915.90

Adicon Holdings Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Adicon Holdings Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Adicon Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1915.899	/	0	*	91
=

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Adicon Holdings's accounts receivable are only considered to be worth 75% of book value:

Adicon Holdings's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1105.001	+	0.75 * 1915.899	+	0.5 * 193.154	-	2980.491
-	0	-	131.821)	/	727.355
=	-0.65

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Adicon Holdings Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Adicon Holdings's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Adicon Holdings (HKSE:09860) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Adicon Holdings Ltd (HKSE:09860) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

ADCNF:USA

Address

No. 208, Zhenzhong Road, West Lake, Zhejiang, Hangzhou, CHN

Website

https://www.adicon.com.cn

Adicon Holdings Ltd is one of the top three independent clinical laboratory or ICL, service providers in China. The company offers comprehensive and best-in-class testing services primarily to hospitals and health check centers through an integrated network of 33 self-operated laboratories across China. The high quality of its services is backed by its strong performance in terms of international accreditation and comprehensive testing menu. Its testing portfolio consists of over 4,000 medical diagnostic tests, including over 1,700 routine tests and over 2,300 esoteric tests. It has three major service platforms. Among them, the inspection service platform consists of clinical, pathology, reproductive genetic, genetic, and mass spectrometry laboratories.

Executives

Cap V General Partner, L.p.	2201 Interest of corporation controlled by you
Cap V, L.l.c.	2201 Interest of corporation controlled by you
Carlyle Asia Partners V, L.p.	2201 Interest of corporation controlled by you
Carlyle Holdings Ii Gp L.l.c.	2201 Interest of corporation controlled by you
Carlyle Holdings Ii L.l.c.	2201 Interest of corporation controlled by you
Cg Subsidiary Holdings L.l.c.	2201 Interest of corporation controlled by you
Pearl Group Limited	2101 Beneficial owner
Tc Group Cayman Investment Holdings L.p.	2201 Interest of corporation controlled by you
Tc Group Cayman Investment Holdings Sub L.p.	2201 Interest of corporation controlled by you
The Carlyle Group Inc.	2201 Interest of corporation controlled by you
Lin Feng
Mega Stream Limited
Trident Trust Company (hk) Limited	2301 Trustee
Ingenuity Capital Holdings Limited	2201 Interest of corporation controlled by you
Corelink Group Limited

Adicon Holdings (HKSE:09860) Headlines

No Headlines